• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Century Therapeutics, Inc. - Common Stock (NQ:IPSC)

2.070 +0.050 (+2.48%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Century Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Century Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
March 19, 2025
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
4 Analysts Have This To Say About Century Therapeutics ↗
January 22, 2025
 
Via Benzinga
News headline image
Century Therapeutics Announces Investigator-Initiated Phase 1/2 Trial of its iPSC-derived iNK Cell Therapy CNTY-101 in B-cell Mediated Autoimmune Diseases Sponsored by Internationally Renowned Key Opinion Leaders
January 21, 2025
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
Century Therapeutics Stages Highest Single Day Move In 11 Months As Casdin Capital Bumps Its Stake To 5.4% ↗
November 28, 2024
 
Via Benzinga
News headline image
5 Analysts Assess Century Therapeutics: What You Need To Know ↗
June 04, 2024
 
Via Benzinga
News headline image
Century Therapeutics: Q4 Earnings Insights ↗
March 14, 2024
 
Via Benzinga
News headline image
Century Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference
November 26, 2024
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 05, 2024
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
Century Therapeutics Announces Upcoming Poster Presentations at the 2024 American Society of Hematology (ASH) Annual Meeting
November 05, 2024
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
Century Therapeutics to Present at Guggenheim’s Inaugural Healthcare Innovation Conference
November 04, 2024
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
October 03, 2024
 
Via Benzinga
News headline image
Century Therapeutics Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Scientific Officer
September 26, 2024
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
Robinhood To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Thursday ↗
August 15, 2024
 
Via Benzinga
News headline image
IPSC Stock Earnings: Century Therapeutics Beats EPS for Q2 2024 ↗
August 08, 2024
IPSC stock results show that Century Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
News headline image
Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
August 08, 2024
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
Century Therapeutics Presents Interim Results from Phase 1 ELiPSE-1 Study at ASCO 2024 Annual Meeting
June 03, 2024
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
Century Therapeutics Presents Preclinical Data Highlighting Advances in iPSC Platform Technology and Programs at 2024 ASGCT Annual Meeting
May 10, 2024
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
IPSC Stock Earnings: Century Therapeutics Beats EPS, Misses Revenue for Q1 2024 ↗
May 09, 2024
IPSC stock results show that Century Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
May 09, 2024
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
April 23, 2024
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
Small-Cap Firm Century Therapeutics' Expands into Autoimmune Diseases, Analyst Says Clade Therapeutics Acquisition Intriguing ↗
April 11, 2024
Century Therapeutics unveils plans to expand CNTY-101 clinical development into additional autoimmune diseases, including systemic lupus erythematosus. $60 million private placement supports R&D... 
Via Benzinga
News headline image
Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics
April 11, 2024
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting
April 08, 2024
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors
March 25, 2024
From Sagimet Biosciences Inc.
Via GlobeNewswire
News headline image
Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
March 19, 2024
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
IPSC Stock Earnings: Century Therapeutics Misses EPS, Misses Revenue for Q4 2023 ↗
March 14, 2024
IPSC stock results show that Century Therapeutics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates
March 14, 2024
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting
March 05, 2024
Posters will highlight Century’s end-to-end cell therapy capabilities including expertise across iPSC reprogramming, gene editing, protein engineering, Allo-Evasion™ technology and computational... 
From Century Therapeutics, Inc.
Via GlobeNewswire
News headline image
3 Millionaire-Maker Under-$10 Stocks to Buy in February 2024 ↗
February 22, 2024
While not on everyone’s radar, these enticing entities just might deliver the goods. 
Via InvestorPlace
News headline image
Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
February 01, 2024
From Century Therapeutics, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap